Online - September 2020: Dr. Spring Behrouz, Ph.D. represented Vincere Biosciences to pitch during the Entrepreneurship World Cup 2020, East Coast Semi-finals. Entrepreneurship World Cup is the world’s largest entrepreneurship ecosystem, with 199 participating countries, more than 150,000 entrepreneurs, and an annual competition to showcase the world’s most innovative startups.
Online - September 2020: Vincere Biosciences is slated to present alongside five other semifinalists during a pitch competition and investor panel hosted by JLABS.
Online - September 2020: Online - September 2020: Andy Lee will present a case study on Drug Discovery Models to Prioritize Pathways and Targets for Parkinson’s Disease during the AI Applications for Drug Discovery & Development Conference as part of the 13th annual Biopharm America and Biotech Week Boston.
Online - July 2020: Dr. Spring Behrouz Ph.D. presents alongside 3 leading researchers in the Parkinson Disease field on July 28 in a webinar titled, “Parkinson’s Disease: Genetics, Disease Mechanisms and Novel Therapeutic Targets.” The speakers will discuss new insights gleaned from the latest research in PD genetics, disease biology, and applications of the identification of PD-associated genes to drug discovery.
Cambridge, MA, USA - April 2020: Vincere Biosciences, Inc has been awarded a Phase I SBIR grant from the National Institute of Neurological Disorders and Stroke to develop inhibitors of USP30...
Santa Fe, NM - February 2020: Kalpana Merchant, Ph.D. gave a talk on technologies that de-risk and enable CNS drug discovery and development, in which she exemplified systems biology combined with NeuroInitiative's computational technology for target ID/validation and discussed the importance of engineering and validating flow scheme assays to garner confidence in the hits using the parkin activator program.
San Francisco, CA - January 2020: Spring Behrouz, PhD selected to present in the Seed Showcase during JPM on Wednesday January 15, 2020.
San Francisco, CA - January 2020: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis during JPM on Sunday January 12, 2020.
Basel, Switzerland - December 2019: Andy Lee will present on Bridging the Gap Between Biology and Technology, sharing how Vincere has implemented unique computational tools and cross-functional teams to accelerate drug discovery.
Lincoln, MA - October 2019: Spring Behrouz, PhD will discuss "Biopharma's AI Scouts" on a panel moderated by Xconomy Editor in Chief Greg Huang.
Boston, MA - September 2019: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis in room 252A at 1:30PM on September 11, 2019.
Cambridge, MA, USA - July 2019: Vincere Biosciences, Inc welcomes Dario Alessi, PhD, Stephen K. Burley, MD, DPhil, and Peter Lansbury, PhD to its Scientific Advisory Board...
Kyoto, Japan - June 2019: Kalpana Merchant, PhD will chair multiple panels and present on the process of taking a therapy from the lab, to the clinic, to the market.
Cambridge, MA, USA - May 2019: Vincere Biosciences, Inc has received a grant from the Michael J Fox Foundation to accelerate the development of small molecule activators...
Mainz, Germany - May 2019: Spring Behrouz, PhD will present the suite of computational drug discovery tools used by Vincere.
San Diego, CA - November 2018: Jason Hall, PhD will present a nansymposium talk entitled "In silico simulation of parkin cellular pathways: Elucidating mechanisms of Parkinson’s disease"
San Diego, CA - November 2018: Andy Lee will present a dynamic poster entitled "Converging pathways in genetic and sporadic Parkinson’s disease: Using unbiased network analysis to connect the dots"
Cambridge, MA, USA - October 2018: Vincere Biosciences, Inc, a Delaware corporation headquartered in Cambridge, MA was created to commercialize a series of therapeutic assets...